Exelixis
EXEL
#1820
Rank
ยฃ8.37 B
Marketcap
ยฃ31.22
Share price
1.11%
Change (1 day)
9.45%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company